Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176579 | SCV000228256 | uncertain significance | not provided | 2015-01-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088213 | SCV001004943 | likely benign | CHARGE association | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000176579 | SCV001781048 | likely benign | not provided | 2020-02-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345603 | SCV002647234 | likely benign | Inborn genetic diseases | 2017-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000176579 | SCV004155861 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CHD7: BP4, BP7 |
Prevention |
RCV003947495 | SCV004763032 | likely benign | CHD7-related condition | 2020-03-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001698991 | SCV001920966 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000176579 | SCV001967980 | likely benign | not provided | no assertion criteria provided | clinical testing |